Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Guilhot

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|May 28, 2013
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow TransplantationH W Auner, R Szydlo, A van Biezen, et al.
Leukemia|March 20, 2009
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapyS Mustjoki, M Ekblom, T P Arstila, et al.
Bone Marrow Transplantation|October 12, 1999
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow TransplantationG Gahrton, H Svensson, B Björkstrand, et al.
Bone Marrow Transplantation|May 1, 1996
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study GroupF Guilhot, A Guerci, D Fiere, et al.
Leukemia|June 13, 2008
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemiaE J Feldman, J Cortes, D J DeAngelo, et al.
Bone Marrow Transplantation|May 1, 1997
Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM)E Jourdan, D Maraninchi, J Reiffers, et al.
Blood|November 8, 2001
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic respondersF Bonifazi, A de Vivo, G Rosti, et al.
Leukemia|April 18, 2002
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phaseF Maloisel, A Guerci, D Guyotat, et al.
Leukemia|July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patientsB Hebraud, X Leleu, V Lauwers-Cances, et al.
Bone Marrow Transplantation|May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working PartyL Bento, A Boumendil, H Finel, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|May 28, 2013
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow TransplantationH W Auner, R Szydlo, A van Biezen, et al.
Leukemia|March 20, 2009
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapyS Mustjoki, M Ekblom, T P Arstila, et al.
Bone Marrow Transplantation|October 12, 1999
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow TransplantationG Gahrton, H Svensson, B Björkstrand, et al.
Bone Marrow Transplantation|May 1, 1996
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study GroupF Guilhot, A Guerci, D Fiere, et al.
Leukemia|June 13, 2008
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemiaE J Feldman, J Cortes, D J DeAngelo, et al.
Bone Marrow Transplantation|May 1, 1997
Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM)E Jourdan, D Maraninchi, J Reiffers, et al.
Blood|November 8, 2001
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic respondersF Bonifazi, A de Vivo, G Rosti, et al.
Leukemia|April 18, 2002
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phaseF Maloisel, A Guerci, D Guyotat, et al.
Leukemia|July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patientsB Hebraud, X Leleu, V Lauwers-Cances, et al.
Bone Marrow Transplantation|May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working PartyL Bento, A Boumendil, H Finel, et al.
Pageof 16